News
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)
23 Apr 24
Biotech, Large Cap, News, Health Care, Top Stories, Markets, General
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
19 Apr 24
Biotech, Government, News, Health Care, Top Stories, Markets, General
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
19 Apr 24
Biotech, Large Cap, News, Penny Stocks, Health Care, FDA, General
Unpacking the Latest Options Trading Trends in Johnson & Johnson
18 Apr 24
Options, Markets
Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future
17 Apr 24
Analyst Color, Biotech, Earnings, Large Cap, News, Health Care, Reiteration, Analyst Ratings, General
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results
17 Apr 24
Earnings, News, Price Target, Markets, Analyst Ratings, Trading Ideas
RBC Capital Maintains Outperform on Johnson & Johnson, Lowers Price Target to $175
17 Apr 24
News, Price Target, Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
17 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
17 Apr 24
News, Penny Stocks, Price Target, Markets, Analyst Ratings, Trading Ideas
B of A Securities Maintains Neutral on Johnson & Johnson, Lowers Price Target to $170
17 Apr 24
News, Price Target, Analyst Ratings
Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
16 Apr 24
Equities, Large Cap, Macro Economic Events, Sector ETFs, Broad U.S. Equity ETFs, Commodities, Treasuries, Econ #s, Top Stories, Economics, Intraday Update, ETFs
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
16 Apr 24
News, Health Care, General
Johnson & Johnson Q1 Earnings Top Wall Street Estimates On Strong Medical Devices Sales, Drugmaker Boosts Annual Outlook
16 Apr 24
Biotech, Earnings, Large Cap, News, Guidance, Health Care, Top Stories, General
Wall Street Braces For Mixed Open As Middle-East Tensions Offset Earnings Optimism: Analyst Points To Silver Lining In Rally Break
16 Apr 24
Earnings, Equities, News, Futures, Previews, Top Stories, Economics, Federal Reserve, Pre-Market Outlook, Markets, Movers, Trading Ideas
Earnings Scheduled For April 16, 2024
16 Apr 24
Earnings
Johnson & Johnson Has Declared 4.2% Increase In Quarterly Dividend, From $1.19 Per Share To $1.24 Per Share
16 Apr 24
Biotech, Large Cap, News, Dividends, Health Care, General
Johnson & Johnson Q1 2024 Adj EPS $2.71 Beats $2.64 Estimate, Sales $21.383B Miss $21.398B Estimate
16 Apr 24
Earnings, Earnings Beats, Earnings Misses, News, Hot
Johnson & Johnson Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
16 Apr 24
Earnings, News, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas
Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday
16 Apr 24
Earnings, News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Trading Ideas
Fear & Greed Index Moves To 'Fear' Zone; S&P 500 Down Over 1%
16 Apr 24
Earnings, News, Small Cap, Pre-Market Outlook, Markets, Trading Ideas
Press releases
Investment Opportunities in Biotech Amidst Federal Rate Uncertainties (ATNM)
22 Apr 24
News, Press Releases
Illinois Jury Awards $45 Million in Mesothelioma Case Against Johnson & Johnson, Kenvue, Inc.
19 Apr 24
Press Releases
Actinium Pharmaceuticals (ATNM) Leads Biotech Innovation Amid Economic Uncertainty
19 Apr 24
News, Press Releases
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
16 Apr 24
Press Releases
Johnson & Johnson Reports Q1 2024 Results
16 Apr 24
Press Releases
SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV
8 Apr 24
Press Releases
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
8 Apr 24
Press Releases
CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy
5 Apr 24
Press Releases
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.
5 Apr 24
Press Releases
Johnson & Johnson to Acquire Shockwave Medical
5 Apr 24
Press Releases
Johnson & Johnson Recommends Shareholders Reject "Mini-Tender" Offer by TRC Capital Investment Corporation
4 Apr 24
Press Releases
Johnson & Johnson to Participate in the BofA Securities Health Care Conference
2 Apr 24
Press Releases
Artelo Biosciences Selected as a Finalist in Johnson & Johnson's Innovation Challenge
12 Mar 24
Health Care, Press Releases
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
11 Mar 24
Press Releases
Johnson & Johnson Completes Acquisition of Ambrx
7 Mar 24
Press Releases
RYBREVANT® (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
1 Mar 24
Press Releases
TECVAYLI® (teclistamab-cqyv) biweekly dosing approved by the U.S. FDA for the treatment of patients with relapsed or refractory multiple myeloma
20 Feb 24
Press Releases
Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
14 Feb 24
Press Releases
Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
12 Feb 24
Press Releases
AMBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAM
10 Feb 24
Press Releases